Hospital Medicare Radiopharmaceuticals 
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
NOVEMBER 1, 2024
Centers for Medicare and Medicaid Services (CMS) has released its final rule for the 2025 Medicare Physician Fee Schedule (MPFS), which includes coverage of colorectal cancer screening with CT colonography (CTC) for the first time. Until this past July , the CMS had chosen not to cover CTC for colorectal cancer screening.
Imaging Technology
NOVEMBER 7, 2024
1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). However, under the previous reimbursement system, diagnostic radiopharmaceuticals were bundled as “supplies,” limiting access in several ways.
AuntMinnie
NOVEMBER 4, 2024
Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. ASTRO also supports short-term relief established through the Medicare Patient Access and Practice Stabilization Act, which would eliminate the looming 2.8%
AuntMinnie
JULY 12, 2024
As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI.
AuntMinnie
JANUARY 11, 2024
The Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion Medical's Scintix biology-guided radiotherapy system. These are created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that targets the cancer itself.
Expert insights. Personalized for you.
52 
Let's personalize your content